
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $164M | $230.2M | $286.5M | $359.6M | $449.6M | |
Revenue Growth (YoY) | 17.69% | 40.38% | 24.44% | 25.51% | 25.03% | |
Cost of Revenues | $3.9M | $5.8M | $3.5M | $4.7M | $5M | |
Gross Profit | $160.1M | $224.5M | $283.1M | $354.9M | $444.6M | |
Gross Profit Margin | 97.63% | 97.5% | 98.8% | 98.7% | 98.89% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $24.4M | $24.3M | $29.5M | $30.7M | $35.2M | |
Other Inc / (Exp) | -$3.5M | -$1.2M | $8.3M | $20.5M | -$7.3M | |
Operating Expenses | $84.7M | $93.3M | $118.1M | $132.8M | $157.6M | |
Operating Income | $75.4M | $131.2M | $164.9M | $222.1M | $287.1M | |
Net Interest Expenses | $29.2M | $33.5M | $37.5M | $50.6M | $75.5M | |
EBT. Incl. Unusual Items | $42.7M | $96.4M | $135.7M | $192.1M | $204.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $212K | $227K | $998K | $636K | $628K | |
Net Income to Company | $42.5M | $96.2M | $134.7M | $191.4M | $203.6M | |
Minority Interest in Earnings | -$255K | -$486K | -$612K | -$708K | -$634K | |
Net Income to Common Excl Extra Items | $42.3M | $95.7M | $134.1M | $190.7M | $203M | |
Basic EPS (Cont. Ops) | $0.44 | $0.82 | $0.99 | $1.25 | $1.16 | |
Diluted EPS (Cont. Ops) | $0.44 | $0.82 | $0.99 | $1.24 | $1.15 | |
Weighted Average Basic Share | $95.3M | $116.4M | $134.9M | $152.1M | $173.9M | |
Weighted Average Diluted Share | $96.2M | $117.5M | $135.9M | $153.5M | $177.1M | |
EBITDA | $131.8M | $199.9M | $264.7M | $346.9M | $405M | |
EBIT | $72.4M | $130.1M | $176.1M | $244.6M | $282.8M | |
Revenue (Reported) | $164M | $230.2M | $286.5M | $359.6M | $449.6M | |
Operating Income (Reported) | $75.4M | $131.2M | $164.9M | $222.1M | $287.1M | |
Operating Income (Adjusted) | $72.4M | $130.1M | $176.1M | $244.6M | $282.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $48.6M | $70.1M | $83.7M | $103.5M | $129.4M | |
Revenue Growth (YoY) | 17.03% | 44.43% | 19.35% | 23.68% | 24.98% | |
Cost of Revenues | $1.4M | $1M | $843K | $993K | $2.3M | |
Gross Profit | $47.1M | $69.1M | $82.8M | $102.5M | $127.1M | |
Gross Profit Margin | 97.09% | 98.56% | 98.99% | 99.04% | 98.26% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6.4M | $8.1M | $8.6M | $9.4M | $11.5M | |
Other Inc / (Exp) | -$1.9M | -$4.4M | $4.2M | -$2.2M | -$899K | |
Operating Expenses | $22.1M | $28.4M | $32.4M | $37.9M | $46.6M | |
Operating Income | $25M | $40.7M | $50.5M | $64.6M | $80.5M | |
Net Interest Expenses | $7.7M | $9.1M | $11.5M | $15.1M | $23.2M | |
EBT. Incl. Unusual Items | $15.4M | $27.1M | $43.2M | $47.3M | $56.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $56K | $301K | $153K | $156K | $158K | |
Net Income to Company | $15.4M | $26.8M | $43.1M | $47.1M | $56.3M | |
Minority Interest in Earnings | -$80K | -$119K | -$160K | -$148K | -$173K | |
Net Income to Common Excl Extra Items | $15.3M | $26.7M | $42.9M | $47M | $56.1M | |
Basic EPS (Cont. Ops) | $0.14 | $0.21 | $0.30 | $0.28 | $0.30 | |
Diluted EPS (Cont. Ops) | $0.14 | $0.21 | $0.29 | $0.28 | $0.29 | |
Weighted Average Basic Share | $107M | $126.8M | $144.4M | $167.3M | $188.5M | |
Weighted Average Diluted Share | $108.1M | $127.9M | $146M | $168.9M | $191M | |
EBITDA | $38.8M | $56.8M | $79.2M | $91.4M | $115.2M | |
EBIT | $23.1M | $36.3M | $55.3M | $62.9M | $80.2M | |
Revenue (Reported) | $48.6M | $70.1M | $83.7M | $103.5M | $129.4M | |
Operating Income (Reported) | $25M | $40.7M | $50.5M | $64.6M | $80.5M | |
Operating Income (Adjusted) | $23.1M | $36.3M | $55.3M | $62.9M | $80.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $171.1M | $251.8M | $300.1M | $379.4M | $475.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $4.9M | $5.4M | $3.3M | $4.8M | $6.3M | |
Gross Profit | $166.2M | $246.4M | $296.8M | $374.6M | $469.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $23.3M | $26M | $30M | $31.5M | $37.3M | |
Other Inc / (Exp) | -$6M | -$3.7M | $17M | $14M | -$6M | |
Operating Expenses | $85.8M | $99.6M | $122.1M | $138.3M | $166.2M | |
Operating Income | $80.3M | $146.9M | $174.7M | $236.3M | $303M | |
Net Interest Expenses | $30.2M | $35M | $39.9M | $54.2M | $83.6M | |
EBT. Incl. Unusual Items | $44.1M | $108.1M | $151.8M | $196.1M | $213.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $237K | $472K | $847K | $641K | $630K | |
Net Income to Company | $43.9M | $107.7M | $151M | $195.5M | $212.8M | |
Minority Interest in Earnings | -$251K | -$525K | -$653K | -$696K | -$659K | |
Net Income to Common Excl Extra Items | $43.6M | $107.1M | $150.3M | $194.8M | $212.1M | |
Basic EPS (Cont. Ops) | $0.43 | $0.88 | $1.08 | $1.23 | $1.18 | |
Diluted EPS (Cont. Ops) | $0.43 | $0.88 | $1.07 | $1.23 | $1.15 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $137.2M | $218M | $287.6M | $359.1M | $428.8M | |
EBIT | $74.6M | $143.2M | $195.2M | $252.2M | $300.2M | |
Revenue (Reported) | $171.1M | $251.8M | $300.1M | $379.4M | $475.5M | |
Operating Income (Reported) | $80.3M | $146.9M | $174.7M | $236.3M | $303M | |
Operating Income (Adjusted) | $74.6M | $143.2M | $195.2M | $252.2M | $300.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $48.6M | $70.1M | $83.7M | $103.5M | $129.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4M | $1M | $843K | $993K | $2.3M | |
Gross Profit | $47.1M | $69.1M | $82.8M | $102.5M | $127.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6.4M | $8.1M | $8.6M | $9.4M | $11.5M | |
Other Inc / (Exp) | -$1.9M | -$4.4M | $4.2M | -$2.2M | -$899K | |
Operating Expenses | $22.1M | $28.4M | $32.4M | $37.9M | $46.6M | |
Operating Income | $25M | $40.7M | $50.5M | $64.6M | $80.5M | |
Net Interest Expenses | $7.7M | $9.1M | $11.5M | $15.1M | $23.2M | |
EBT. Incl. Unusual Items | $15.4M | $27.1M | $43.2M | $47.3M | $56.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $56K | $301K | $153K | $156K | $158K | |
Net Income to Company | $15.4M | $26.8M | $43.1M | $47.1M | $56.3M | |
Minority Interest in Earnings | -$80K | -$119K | -$160K | -$148K | -$173K | |
Net Income to Common Excl Extra Items | $15.3M | $26.7M | $42.9M | $47M | $56.1M | |
Basic EPS (Cont. Ops) | $0.14 | $0.21 | $0.30 | $0.28 | $0.30 | |
Diluted EPS (Cont. Ops) | $0.14 | $0.21 | $0.29 | $0.28 | $0.29 | |
Weighted Average Basic Share | $107M | $126.8M | $144.4M | $167.3M | $188.5M | |
Weighted Average Diluted Share | $108.1M | $127.9M | $146M | $168.9M | $191M | |
EBITDA | $38.8M | $56.8M | $79.2M | $91.4M | $115.2M | |
EBIT | $23.1M | $36.3M | $55.3M | $62.9M | $80.2M | |
Revenue (Reported) | $48.6M | $70.1M | $83.7M | $103.5M | $129.4M | |
Operating Income (Reported) | $25M | $40.7M | $50.5M | $64.6M | $80.5M | |
Operating Income (Adjusted) | $23.1M | $36.3M | $55.3M | $62.9M | $80.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $26.6M | $59.8M | $62.3M | $39.8M | $40.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $63.2M | $83.6M | $101.6M | $140.2M | $173.4M | |
Inventory | $17.1M | $15.4M | $4.8M | $7.5M | $10M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $265.5M | $348.1M | $417.9M | $420.5M | $580.4M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.5B | $3.3B | $4B | $4.8B | $5.8B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $16.8M | $32.1M | $29.3M | $31.2M | $35.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $42.5M | $64.8M | $68.7M | $78.4M | $90.8M | |
Long-Term Debt | $815.3M | $1.2B | $1.4B | $1.7B | $2.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $906.9M | $1.3B | $1.5B | $1.8B | $2.2B | |
Common Stock | $1.1M | $1.2M | $1.4M | $1.6M | $1.9M | |
Other Common Equity Adj | -$37.2M | -$14.8M | $40.7M | $4M | $16.9M | |
Common Equity | $1.6B | $2B | $2.5B | $3B | $3.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $7.2M | $7.2M | $8.5M | $8.4M | $8.4M | |
Total Equity | $1.6B | $2B | $2.5B | $3B | $3.6B | |
Total Liabilities and Equity | $2.5B | $3.3B | $4B | $4.8B | $5.8B | |
Cash and Short Terms | $26.6M | $59.8M | $62.3M | $39.8M | $40.7M | |
Total Debt | $815.3M | $1.2B | $1.4B | $1.7B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $42.8M | $14.3M | $71M | $79.2M | $47M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $69.3M | $92M | $111.6M | $144.6M | $193.3M | |
Inventory | -- | $14.5M | $5.4M | $1.2M | $3.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $290.1M | $343.9M | $419.7M | $460.9M | $598.5M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.7B | $3.5B | $4.1B | $5B | $6.1B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $16.5M | $24.7M | $25.8M | $25.8M | $25.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $76K | -- | |
Total Current Liabilities | $42.9M | $59M | $67M | $76.1M | $84.5M | |
Long-Term Debt | $934.6M | $1.2B | $1.4B | $1.7B | $2.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $1.2B | $1.5B | $1.8B | $2.2B | |
Common Stock | $1.1M | $1.3M | $1.5M | $1.8M | $2M | |
Other Common Equity Adj | -$19.2M | $14M | $26M | $23.6M | -$5.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $7.2M | $7.4M | $8.4M | $8.5M | $8.3M | |
Total Equity | $1.7B | $2.2B | $2.6B | $3.2B | $3.8B | |
Total Liabilities and Equity | $2.7B | $3.5B | $4.1B | $5B | $6.1B | |
Cash and Short Terms | $42.8M | $14.3M | $71M | $79.2M | $47M | |
Total Debt | $934.6M | $1.2B | $1.4B | $1.7B | $2.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $42.5M | $96.2M | $134.7M | $191.4M | $203.6M | |
Depreciation & Amoritzation | $59.4M | $69.9M | $88.3M | $101.9M | $121.9M | |
Stock-Based Compensation | $6.1M | $5.7M | $9.5M | $9M | $10.8M | |
Change in Accounts Receivable | -$12.1M | $2.2M | $4.5M | -$6M | -$7.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $99.4M | $167.4M | $211M | $254.6M | $308.5M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$545.5M | -$829.7M | -$706.1M | -$857.1M | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$86.5M | -$112.3M | -$141.7M | -$168.2M | -$199.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $267M | $789.6M | $696.5M | $318M | $664.6M | |
Long-Term Debt Repaid | -$180.9M | -$442.8M | -$443M | -$70M | -$220M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.8M | -$3.7M | -$8.9M | -$7M | -$4.5M | |
Cash From Financing | $457.8M | $689.1M | $506.8M | $580M | $810.7M | |
Beginning Cash (CF) | $21.3M | $33M | $59.8M | $71.5M | $49M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.7M | $26.8M | $11.7M | -$22.5M | -$4M | |
Ending Cash (CF) | $33M | $59.8M | $71.5M | $49M | $45M | |
Levered Free Cash Flow | $99.4M | $167.4M | $211M | $254.6M | $308.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $15.4M | $26.8M | $43.1M | $47.1M | $56.3M | |
Depreciation & Amoritzation | $15.7M | $20.5M | $23.7M | $28.4M | $35M | |
Stock-Based Compensation | $1.6M | $2.8M | $2.7M | $2.9M | $4M | |
Change in Accounts Receivable | -$2.5M | -$1.6M | -$2.1M | $411K | -$1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $30.1M | $44.1M | $53.7M | $66.8M | $77.2M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$175.3M | -$211.6M | -$159.2M | -$230.7M | -$284.1M | |
Dividends Paid (Ex Special Dividend) | -$25.7M | -$32.6M | -$39.4M | -$47.2M | -$55.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $120M | $148M | -- | -- | $155M | |
Long-Term Debt Repaid | -$1M | -$145M | -- | -- | -$155M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.2M | -$6.8M | -$2.9M | -$3.4M | -$14M | |
Cash From Financing | $157M | $122M | $105M | $194.2M | $209M | |
Beginning Cash (CF) | $33M | $59.8M | $71.5M | $49M | $45M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.8M | -$45.5M | -$542K | $30.2M | $2M | |
Ending Cash (CF) | $44.8M | $14.3M | $71M | $79.2M | $47M | |
Levered Free Cash Flow | $30.1M | $44.1M | $53.7M | $66.8M | $77.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $43.9M | $107.7M | $151M | $195.5M | $212.8M | |
Depreciation & Amoritzation | $62M | $74.7M | $91.6M | $106.6M | $128.4M | |
Stock-Based Compensation | $6.2M | $6.9M | $9.4M | $9.2M | $11.9M | |
Change in Accounts Receivable | -$16.5M | $3.1M | $4M | -$3.4M | -$8.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $103.2M | $181.4M | $220.6M | $267.6M | $318.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$572.7M | -$865.9M | -$653.7M | -$928.7M | -$1.2B | |
Dividends Paid (Ex Special Dividend) | -$92.8M | -$119.2M | -$148.5M | -$176M | -$208.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $138M | $817.6M | -- | $318M | $819.6M | |
Long-Term Debt Repaid | -$68.9M | -$586.8M | -- | -$70M | -$375M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.8M | -$9.3M | -$5M | -$7.6M | -$15.1M | |
Cash From Financing | $300.2M | $654M | $489.8M | $669.2M | $825.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$169.3M | -$30.6M | $56.7M | $8.2M | -$32.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $103.2M | $181.4M | $220.6M | $267.6M | $318.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $15.4M | $26.8M | $43.1M | $47.1M | $56.3M | |
Depreciation & Amoritzation | $15.7M | $20.5M | $23.7M | $28.4M | $35M | |
Stock-Based Compensation | $1.6M | $2.8M | $2.7M | $2.9M | $4M | |
Change in Accounts Receivable | -$2.5M | -$1.6M | -$2.1M | $411K | -$1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $30.1M | $44.1M | $53.7M | $66.8M | $77.2M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$175.3M | -$211.6M | -$159.2M | -$230.7M | -$284.1M | |
Dividends Paid (Ex Special Dividend) | -$25.7M | -$32.6M | -$39.4M | -$47.2M | -$55.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $120M | $148M | -- | -- | $155M | |
Long-Term Debt Repaid | -$1M | -$145M | -- | -- | -$155M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.2M | -$6.8M | -$2.9M | -$3.4M | -$14M | |
Cash From Financing | $157M | $122M | $105M | $194.2M | $209M | |
Beginning Cash (CF) | $33M | $59.8M | $71.5M | $49M | $45M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.8M | -$45.5M | -$542K | $30.2M | $2M | |
Ending Cash (CF) | $44.8M | $14.3M | $71M | $79.2M | $47M | |
Levered Free Cash Flow | $30.1M | $44.1M | $53.7M | $66.8M | $77.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.